Chronic Obstructive Pulmonary Disease

Do kids grow out of childhood asthma?

When a child is diagnosed with asthma, parents usually have a number of questions. How serious is asthma? Will the child grow out of it? How can it be treated? It can be difficult to get clear answers, as asthma affects different ...

Jul 18, 2016
popularity7 comments 0

Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive respiratory disease (CORD), is the co-occurrence of chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs, causing shortness of breath (dyspnea). In clinical practice, COPD is defined by its characteristically low airflow on lung function tests. In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time. In England, an estimated 842,100 of 50 million people have a diagnosis of COPD.

COPD is caused by noxious particles or gas, most commonly from tobacco smoking, which triggers an abnormal inflammatory response in the lung.

The diagnosis of COPD requires lung function tests. Important management strategies are smoking cessation, vaccinations, rehabilitation, and drug therapy (often using inhalers). Some patients go on to require long-term oxygen therapy or lung transplantation.

Worldwide, COPD ranked as the sixth leading cause of death in 1990. It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries. COPD is the third leading cause of death in the U.S. and the economic burden of COPD in the U.S. in 2007 was $42.6 billion in health care costs and lost productivity.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

New genetic clues into motor neuron disease

Researchers at The University of Queensland have contributed to the discovery of three new genes which increase the risk of motor neuron disease (MND), opening the door for targeted treatments.

'Pac-Man' gene implicated in Alzheimer's disease

A gene that protects the brain from the harmful build-up of amyloid-beta, one of the causative proteins implicated in Alzheimer's disease, has been identified as a new target for therapy by NeuRA researchers.

Male hormone reverses cell aging in clinical trial

Telomerase, an enzyme naturally found in cells, is often described as a "cellular elixir of youth." In a recent study, Brazilian and U.S. researchers show that sex hormones can stimulate production of this enzyme.